loader image


Emerging trends in the biotechnological sector

Emerging trends in the biotechnological sector

Change is the only constant in this world. Every day, new technological breakthroughs and advances in knowledge bring about changes in every aspect of daily life. Biotechnology is one of the businesses that is constantly changing due to continual study, technological advancements, and scientific discoveries. The global pandemic has pushed biotech development and adoption in the hopes of finding new answers to key global concerns such as disease, food shortages, and environmental degradation. This article focuses on emerging trends in the biotechnological sector and how it will impact our future.

Let us first understand what is Biotechnology?

Biotechnology is the use of biology to the solution of problems and the creation of useful products. Modern biotechnology offers ground-breaking products and solutions to cure severe and uncommon diseases, minimise our environmental impact, feed the hungry, utilise less and cleaner energy, and improve the safety, cleanliness, and efficiency of industrial manufacturing processes.

Emerging trends in the biotechnological sector

  • 3-D Bioprinting

Biotechnology can generate diverse human body components for use in medicine, such as heart valves, skin, and cartilage, by using living cells. Researchers created a bioink using a combination of materials such as cells, hydrogels, and growth factors, which are proteins that induce tissue growth. BICO, the world’s leading bio convergence company, and Organovo Holdings, Inc., a biotechnology company specialising in 3D bioprinting to aid drug development, recently announced a new licencing agreement on bioprinting patents. The patent covers a wide range of topics, including bioprinters with one or more print heads, devices, systems, and methods of fabricating tissues.

  • Novel Natural Ingredients

The US patent office has awarded three patents to Purissima, Inc, a prominent next-generation biotechnology health and wellness company. Purissima’s innovative platform can manufacture an almost infinite library of natural components, including those with compelling antibacterial, anti-inflammatory, and antiviral capabilities, using technological developments to access rare and novel molecules without endangering the environment. This company continues to expand the impact of biosynthetic production by identifying the promising potential of these compounds to positively address neurological and neurodegenerative conditions, chronic pain, behavioural and cognition disorders, inflammation, oxidation-related conditions, and metabolic disorders.

  • Digital Assessment, Diagnosis, and Treatment of Patients

Too far, a large number of physicians and healthcare practitioners have been granted accreditation to practice online. Virtual diagnostics are available because companies like Virtual Health, who provide wireless device assistants. Some medical practitioners can even prescribe medications through their virtual clinics using LiveHealth Online or Teladoc’s online database access. Telepractice is becoming more popular in the biotech industry. As a result of modern biotechnology-based demonstration gadgets, many illnesses and ailments can be identified more quickly and with more precision. Without fasting, a blood test developed using biotechnology calculates low-thickness lipoprotein (“bad” cholesterol) in one test.

  • Personalized medicine and platforms

Because of modern genomics, it is now feasible to customise the formulation of medicines for individuals based on their DNA makeup. Personalized medicine can currently be used to better understand aspects such as how a person’s genetic makeup influences the way malignant cells develop and spread in their bodies, allowing better treatment decisions to be made. Personalized medicine will be a major focus in 2022, and researchers are optimistic that it will result in more effective and efficient therapies for a variety of ailments.

The United States Patent and Trademark Office (USPTO) recently granted Vineti, Inc., the leading digital platform of record for cell and gene therapies, a patent (U.S. Patent No. 11,271,741) devoted to a customised medical platform.

  • Artificial meat

Lab-grown meat entails growing tissue from muscle and fat cells in a lab and has the potential to drastically reduce the amount of energy, land, and water used by the cattle sector – as well as methane emissions, which are widely acknowledged as a major contributor to climate change! The biotech techniques for manufacturing meat emerged from procedures originally designed to help cure injuries in humans or animals by regrowing damaged cells — for example, growing skin cells to be transplanted onto burn victims. A number of companies, notably a food delivery company Just Eat, are preparing to create their own artificial meat, with 2022 perhaps being the year when it becomes readily available.

The biotechnology business is critical for improving people’s lives, enhancing their welfare, stabilising the economy, and providing alternative materials manufacturing methods. As more financing and interest is granted, the aforementioned are expected trends in the biotech industry.

The developments discussed in this article are merely the tip of the iceberg, for example personalised medicine, data management, and bio manufacturing, are all predicted to grow.

Wissen Research assists biotechnology practitioners in identifying new growth prospects, understanding the effect of developing technology, and driving innovation through our technology research and market intelligence service. Contact us to learn more about the emerging trends in biotechnology.